-
Something wrong with this record ?
Antimicrobial nanofibrous mats with controllable drug release produced from hydrophobized hyaluronan
L. Bardoňová, A. Kotzianová, K. Skuhrovcová, O. Židek, T. Bártová, J. Kulhánek, T. Hanová, K. Mamulová Kutláková, H. Vágnerová, V. Krpatová, M. Knor, J. Starigazdová, P. Holomková, R. Buffa, V. Velebný
Language English Country Great Britain
Document type Journal Article
- MeSH
- Anti-Bacterial Agents chemistry pharmacology toxicity MeSH
- 3T3 Cells MeSH
- Hydrophobic and Hydrophilic Interactions MeSH
- Imines chemistry pharmacology toxicity MeSH
- Hyaluronic Acid chemistry pharmacology toxicity MeSH
- Delayed-Action Preparations chemistry pharmacology toxicity MeSH
- Microbial Sensitivity Tests MeSH
- Mice MeSH
- Nanofibers chemistry toxicity MeSH
- Drug Carriers chemistry pharmacology toxicity MeSH
- Pseudomonas aeruginosa drug effects MeSH
- Pyridines chemistry pharmacology toxicity MeSH
- Staphylococcus aureus drug effects MeSH
- Triclosan chemistry pharmacology toxicity MeSH
- Drug Liberation MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Due to their large active surface, high loading efficiency, and tunable dissolution profiles, nanofibrous mats are often cited as promising drug carriers or antimicrobial membranes. Hyaluronic acid has outstanding biocompatibility, but it is hydrophilic. Nanofibrous structures made from hyaluronan dissolve immediately, making them unsuitable for controlled drug release and longer applications. We aimed to prepare a hyaluronan-based antimicrobial nanofibrous material, which would retain its integrity in aqueous environments. Self-supporting nanofibrous mats containing octenidine dihydrochloride or triclosan were produced by electrospinning from hydrophobized hyaluronan modified with a symmetric lauric acid anhydride. The nanofibrous mats required no cross-linking to be stable in PBS for 7 days. The encapsulation efficiency of antiseptics was nearly 100%. Minimal release of octenidine was observed, while up to 30% of triclosan was gradually released in 72 h. The nanofibrous materials exhibited antimicrobial activity, the fibroblast viability was directly dependent on the antiseptic content and its release.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003791
- 003
- CZ-PrNML
- 005
- 20250318144509.0
- 007
- ta
- 008
- 220113e20210519xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.carbpol.2021.118225 $2 doi
- 035 __
- $a (PubMed)34119178
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Bardoňová, Lenka $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic; Nanotechnology Centre, Energy and Environmental Technology Centre, VŠB - Technical University of Ostrava, 17. listopadu 2172/15, 708 00 Ostrava, Czech Republic. Electronic address: bardonova@contipro.com
- 245 10
- $a Antimicrobial nanofibrous mats with controllable drug release produced from hydrophobized hyaluronan / $c L. Bardoňová, A. Kotzianová, K. Skuhrovcová, O. Židek, T. Bártová, J. Kulhánek, T. Hanová, K. Mamulová Kutláková, H. Vágnerová, V. Krpatová, M. Knor, J. Starigazdová, P. Holomková, R. Buffa, V. Velebný
- 520 9_
- $a Due to their large active surface, high loading efficiency, and tunable dissolution profiles, nanofibrous mats are often cited as promising drug carriers or antimicrobial membranes. Hyaluronic acid has outstanding biocompatibility, but it is hydrophilic. Nanofibrous structures made from hyaluronan dissolve immediately, making them unsuitable for controlled drug release and longer applications. We aimed to prepare a hyaluronan-based antimicrobial nanofibrous material, which would retain its integrity in aqueous environments. Self-supporting nanofibrous mats containing octenidine dihydrochloride or triclosan were produced by electrospinning from hydrophobized hyaluronan modified with a symmetric lauric acid anhydride. The nanofibrous mats required no cross-linking to be stable in PBS for 7 days. The encapsulation efficiency of antiseptics was nearly 100%. Minimal release of octenidine was observed, while up to 30% of triclosan was gradually released in 72 h. The nanofibrous materials exhibited antimicrobial activity, the fibroblast viability was directly dependent on the antiseptic content and its release.
- 650 _2
- $a buňky 3T3 $7 D016475
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antibakteriální látky $x chemie $x farmakologie $x toxicita $7 D000900
- 650 _2
- $a léky s prodlouženým účinkem $x chemie $x farmakologie $x toxicita $7 D003692
- 650 _2
- $a nosiče léků $x chemie $x farmakologie $x toxicita $7 D004337
- 650 _2
- $a uvolňování léčiv $7 D065546
- 650 _2
- $a kyselina hyaluronová $x chemie $x farmakologie $x toxicita $7 D006820
- 650 _2
- $a hydrofobní a hydrofilní interakce $7 D057927
- 650 _2
- $a iminy $x chemie $x farmakologie $x toxicita $7 D007097
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a nanovlákna $x chemie $x toxicita $7 D057139
- 650 _2
- $a Pseudomonas aeruginosa $x účinky léků $7 D011550
- 650 _2
- $a pyridiny $x chemie $x farmakologie $x toxicita $7 D011725
- 650 _2
- $a Staphylococcus aureus $x účinky léků $7 D013211
- 650 _2
- $a triclosan $x chemie $x farmakologie $x toxicita $7 D014260
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kotzianová, Adéla $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: kotzianova@contipro.com
- 700 1_
- $a Skuhrovcová, Kristýna $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: skuhrovcova@contipro.com
- 700 1_
- $a Židek, Ondřej $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: zidek@contipro.com
- 700 1_
- $a Bártová, Tereza $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: bartova@contipro.com
- 700 1_
- $a Kulhánek, Jaromír $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: kulhanek@contipro.com
- 700 1_
- $a Hanová, Tereza $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: hanova@contipro.com
- 700 1_
- $a Mamulová Kutláková, Kateřina $u Nanotechnology Centre, Energy and Environmental Technology Centre, VŠB - Technical University of Ostrava, 17. listopadu 2172/15, 708 00 Ostrava, Czech Republic. Electronic address: katerina.mamulova.kutlakova@vsb.cz
- 700 1_
- $a Vágnerová, Hana $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: vagnerova@contipro.com
- 700 1_
- $a Krpatová, Věra $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: krpatova@contipro.com
- 700 1_
- $a Knor, Michal $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: michal.knor@seznam.cz
- 700 1_
- $a Starigazdová, Jana $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: starigazdova@contipro.com
- 700 1_
- $a Holomková, Pavlína $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: holomkova@contipro.com
- 700 1_
- $a Buffa, Radovan $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: buffa@contipro.com $7 xx0330178
- 700 1_
- $a Velebný, Vladimír $u CONTIPRO a.s., Dolní Dobrouč 401, 561 02, Czech Republic. Electronic address: velebny@contipro.com
- 773 0_
- $w MED00006149 $t Carbohydrate polymers $x 1879-1344 $g Roč. 267 (20210519), s. 118225
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34119178 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20250318144506 $b ABA008
- 999 __
- $a ok $b bmc $g 1751296 $s 1154940
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 267 $c - $d 118225 $e 20210519 $i 1879-1344 $m Carbohydrate polymers $n Carbohydr Polym $x MED00006149
- LZP __
- $a Pubmed-20220113